AI Protocol Authoring For Clinical Trials
Protocol design and writing grounded in evidence from prior trials, real-world data, literature, and your own organizational memory, with governance built into the draft.
“We amended three times. What were we designing against?”
Protocol design is too often made without the evidence that already exists, and authoring is cut-and-paste at scale. The average clinical trial protocol now contains more than 20 endpoints and hundreds of operational procedures (Tufts CSDD), so every inconsistency becomes rework later.
Evidence & feasibility first
Synthesizes prior trials, real-world data and literature, validates I/E criteria against patient populations, and delivers a structured, evidence-grounded synopsis.
From bottleneck to convergence
AI-backed drafting turns governance from a six-week bottleneck into convergence.
Innovo Copilot
How Innovo Copilot Handles Protocol Authoring
Plan and Author, on one intelligence layer
Evidence-backed drafting with AI QC agents
Auto-drafts ICF, CRF & DMP from the approved protocol
Generates RACT, TMP & SMP from the protocol
Built-in checks for FDA, EMA, and PMDA guidance alignment from the first draft
The Outcomes Clinical Teams Care About
-
50%+
Faster authoring: reduction in medical writing cycles
-
Up to 40%
Shorter path from concept to finalized protocol
-
300M+
Records for feasibility validation
Frequently Asked Questions
Plain answers on protocol authoring.
-
Innovo Copilot. Its Author capability drafts protocol sections with evidence-backed language and AI QC agents, then auto-drafts the ICF, CRF and DMP from the approved protocol. Teams shift from blank-page writing to high-level reviewing.
-
Prior trials, real-world data, literature, and your own organizational memory. Innovo Copilot validates I/E criteria against patient populations, with 300M+ records for feasibility validation, and delivers a structured, evidence-grounded synopsis.
-
Yes. A protocol can be uploaded as PDF, Word, or a structured file. It is mapped to the Unified Study Definitions Model (USDM) and kept in a structured, version-controlled repository.
-
Innovo Copilot provides verified source attribution for AI claims, with data lineage and audit trails for every AI-generated insight.
Part Of Innovo Copilot
Protocol authoring is one part of a closed loop: Plan → Author → Monitor. Every phase feeds the next. More solutions: Amendments & Deviations · Risk-Based Monitoring & CAPA · Sponsor Oversight & ICH E6(R3) · Study Startup.
Ready To Accelerate Clinical Trial Execution?
Connect with our team today to see how the Innovo platform can transform your operational efficiency.